• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Foregoing antibiotics in pediatric outpatients with suspected pneumonia may be a safe option

byAlex Gipsman, MDandCordelia Ross
March 19, 2020
in Infectious Disease, Pediatrics, Public Health, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In children aged 3 months to 18 years discharged from the emergency department (ED) with suspected community-acquired pneumonia (CAP), similar treatment failure rates were observed between children who received antibiotics and those who did not.

2. Secondary outcomes, including ED revisits within 30 days and parent-reported quality of life measures, were also similar between the 2 groups.

Evidence Rating Level: 2 (Good)

Study Rundown: A significant percentage of children diagnosed with pneumonia are infected by viral pathogens and therefore would not benefit from antibiotic therapy. However, distinguishing between viral and bacterial pneumonia is often not possible. Authors of this study sought to determine whether rates of treatment failure in patients discharged from the ED with a presumed diagnosis of pneumonia differed between children who received antibiotics and those who did not. Results indicated no difference in treatment failure rates between the 2 groups. Additionally, quality of life measures reported by parents during a follow up phone call did not significantly differ. These findings suggest that well-appearing children with a presumed diagnosis of community acquired pneumonia who are not admitted to the hospital may safely be managed without antibiotics. The study was limited by a small sample size (337 patients) and a cohort study design that saw major baseline characteristics differ between the 2 groups of patients, which may have led to confounding despite statistical adjustment. Finally, the median age in the study was 3.4 years, and viruses are responsible for the majority of pneumonia in pre-school aged children, which could explain the low treatment-failure rates in those not treated with antibiotics.

Click to read the study in Pediatrics

Relevant Reading: IDSA CAP management guidelines in children older than 3 months

In-Depth [prospective cohort]: Study participants included a total of 337 children aged 3 to 18 months seen in the ED with signs and symptoms of pneumonia (cough, sputum production, chest pain, dyspnea, tachypnea, or abnormal pulmonary findings on physical exam). Patients were divided into 2 groups – those prescribed antibiotics and those who were not. Primary outcome was treatment failure, defined as a return visit with hospitalization for pneumonia within the next 30 days, return visit with a change in antibiotics within 30 days, or change in antibiotics by a physician at any time in the next 15 days, as reported by parents. Secondary outcomes included ED revisits within 30 days and quality of life measures as reported by parents, such as duration of symptoms, return to normal activity, other symptoms such as vomiting or diarrhea, and subsequent medical visits required. Propensity scoring was used for a number of variables (fever, duration of illness, physical exam findings) in an attempt to estimate the probability of receiving antibiotics with each of those variables; patients were subsequently matched based on their propensity scores. Notably, CXR findings were not included in propensity matching due to previous research indicating no impact of CXR results on antibiotic prescribing. However, only 1 patient in the group not treated with antibiotics had a CXR consistent with pneumonia, compared with 68 patients in the group prescribed antibiotics. Overall, 8.8% of children experienced treatment failure, with no differences seen between the 2 groups. After adjustment for CXR result differences between the two groups, there were still no differences in treatment failure rates. Additionally, there were no statistically significant differences between the groups for secondary outcome measures, such as time to return of normal activity (average 2 days for each group).

RELATED REPORTS

#VisualAbstract: New-onset atrial fibrillation following hospitalization for pneumonia associated with increased thromboembolic risk

New-onset atrial fibrillation following hospitalization for pneumonia associated with increased thromboembolic risk

Clinical response to Gram stain-guided antibiotic therapy noninferior to that of guideline-based therapy in patients with ventilator-associated pneumonia

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antibioticsChest X-Raydiarrheafeverpneumoniavomiting
Previous Post

Early aortic valve replacement linked with improved outcomes versus conservative management

Next Post

2 Minute Medicine Rewind March 16, 2020

RelatedReports

#VisualAbstract: New-onset atrial fibrillation following hospitalization for pneumonia associated with increased thromboembolic risk
StudyGraphics

#VisualAbstract: New-onset atrial fibrillation following hospitalization for pneumonia associated with increased thromboembolic risk

June 28, 2022
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

New-onset atrial fibrillation following hospitalization for pneumonia associated with increased thromboembolic risk

May 30, 2022
Prescription of antibiotics for acute respiratory infections increasing
Infectious Disease

Clinical response to Gram stain-guided antibiotic therapy noninferior to that of guideline-based therapy in patients with ventilator-associated pneumonia

April 14, 2022
Of Background Image
Chronic Disease

Melioidosis outbreak is associated with imported aromatherapy spray

March 9, 2022
Next Post
Solitary kidney not associated with contrast-induced nephropathy

2 Minute Medicine Rewind March 16, 2020

Quick Take: State Gun Laws, Gun Ownership, and Mass Shootings in the US: Cross-Sectional Time Series

Morbidity and mortality associated with gun violence in the United States

Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial

MRI-targeted biopsies alone may underestimate grade of prostate cancer 

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early exposure to allergenic foods may reduce incidence of long-term food allergy
  • Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic
  • Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.